Bayer’s Premise® receives GreenPro certification from IGBC
Mumbai, November 4, 2020: Premise®, Bayer’s trusted termite-control brand has been awarded the GreenPro certification by the Indian Green Building Council (IGBC), a part of the Confederation of Indian Industries (CII). Premise is India’s first termiticide to be awarded the GreenPro certification, which honors outstanding green building products and technologies. Customers planning to get an IGBC certificate for their building will receive one credit point for using Premise®.
Launched in India in 2004, Premise® is used for anti-termite treatment in the pre-construction and post-construction segment. Over the last five years, Premise® has protected over 250 million square feet of constructed buildings in India. Premise® has also been used to termite-proof the base of the iconic, 597 feet tall, Statue of Unity in Gujarat.
Speaking about the certification for Premise®, Dr. Arun Kumar, Head of Environmental Science, Bayer South Asia, said, “The GreenPro certification for Premise® is an endorsement of Bayer’s sustainability commitments towards greener and cleaner products. We are delighted that Premise® is India’s first termiticide to win this recognition by the CII-IGBC.”
The active ingredient in Premise® is Imidacloprid, which is a low dosage (2.1 ml/ litre solution for application) molecule which works extremely well for colony management of termites. In comparison to alternatives which work by repelling termites, Imidacloprid works through a non-repellant technique; where the termite is exposed to the chemical which is later transferred to the other members of the termite colony. This technology is odorless and is water-based, making it a highly desirable option for safe and easy application.
Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. Its products and services are designed to benefit people by supporting efforts to overcome the major challenges presented by a growing and aging global population. At the same time, the Group aims to increase its earning power and create value through innovation and growth. Bayer is committed to the principles of sustainable development, and the Bayer brand stands for trust, reliability and quality throughout the world. In fiscal 2019, the Group employed around 104,000 people and had sales of € 43.5 billion. Capital expenditures amounted to € 2.9 billion and R&D expenses to € 5.3 billion.
For more information, go to www.bayer.com.
Communications, Bayer CropScience Limited
This release may contain forward-looking statements based on current assumptions and forecasts made by Bayer management. Various known and unknown risks, uncertainties and other factors could lead to material differences between the actual future results, financial situation, development or performance of the company and the estimates given here. These factors include those discussed in Bayer’s public reports, which are available on the Bayer website at www.bayer.com. The company assumes no liability whatsoever to update these forward-looking statements or to conform them to future events or developments.